- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/31 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Micrococcaceae (F) provenant de Staphylococcus (G)
Détention brevets de la classe C07K 14/31
Brevets de cette classe: 829
Historique des publications depuis 10 ans
|
54
|
58
|
69
|
58
|
58
|
51
|
60
|
53
|
45
|
34
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Cytiva BioProcess R&D AB | 327 |
58 |
| Affibody AB | 113 |
33 |
| The University of Chicago | 1505 |
28 |
| Navigo Proteins GmbH | 138 |
25 |
| Roche Sequencing Solutions, Inc. | 738 |
23 |
| Glaxosmithkline Biologicals S.A. | 1602 |
21 |
| Kaneka Corporation | 4775 |
16 |
| Children's Medical Center Corporation | 1969 |
15 |
| New York University | 1853 |
15 |
| The Regents of the University of California | 20902 |
12 |
| Evaxion Biotech A/S | 43 |
12 |
| GE Healthcare Bio-Sciences AB | 506 |
10 |
| EMD Millipore Corporation | 634 |
9 |
| The Trustees of the University of Pennsylvania | 4437 |
9 |
| The Johns Hopkins University | 5938 |
8 |
| GE Healthcare BioProcess R&D AB | 42 |
8 |
| Abvacc, Inc. | 13 |
8 |
| Bristol-myers Squibb Company | 4757 |
7 |
| JSR Corporation | 2553 |
7 |
| Repligen Corporation | 300 |
7 |
| Autres propriétaires | 498 |